SER — Serina Therapeutics, Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1708599 ·
Last close
$2.63
Market Cap
$66.80M
52W High
$2.92
52W Low
$1.70
ADV30
51,939
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -6,280,000 | -6,898,000 | 27,299,000 | 24,526,000 | 9,671,000 |
| Dec 2025 | 0 | — | -6,207,000 | -3,336,000 | 6,951,000 | 3,056,000 | 6,988,000 |
| Sep 2025 | 0 | — | -6,392,000 | -4,585,000 | 12,413,000 | 8,620,000 | 10,819,000 |
| Jun 2025 | 0 | — | -5,565,000 | -6,448,000 | 8,941,000 | 6,041,000 | 7,295,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-18,201,000
Investing CF
$-84,000
Financing CF
$38,552,000
CapEx
$-43,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.18
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-70,398,000
Inventory
—
Receivables
—
ST Investments
$0
EBIT TTM
$-20,864,000
Pretax Income TTM
$-21,266,000
Interest Exp TTM
$402,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$0
EBITDA
$-25,587,000
Free Cash Flow
$-12,350,875
Enterprise Value
$53,629,356
Total Cash
$23,024,000
Total Debt
$3,754,000
Shares Out
25,400,473
Trailing EPS
$-1.87
Book Value
$0.85
ROE
-207.9%
ROA
-92.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -24,022,000 | -19,182,000 | 6,951,000 | 6,988,000 | — | -17,955,000 |
| Dec 2024 | 0 | -17,048,000 | -11,141,000 | 6,724,000 | 6,216,000 | — | -17,137,000 |
| Dec 2023 | 3,000,000 | -3,129,000 | 5,269,000 | 8,968,000 | 41,262,000 | — | -2,476,000 |
| Dec 2022 | 500,000 | -2,270,368 | -2,682,108 | 858,042 | 38,636,203 | — | -2,075,624 |
TTM Snapshot
Revenues TTM
$43,000
NetIncome TTM
$3,162,000
OpCashFlow TTM
$0
Assets (Latest)
$6,724,000
Forward EPS
$-1.05
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| APLM | Apollomics Inc. | $66.92M | $23.11 | — |
| RLFTY | MindMaze Therapeutics Holding SA | $66.59M | $0.42 | — |
| BOLD | Boundless Bio, Inc. | $67.33M | $2.96 | — |
| INCR | Intercure Ltd. | $64.91M | $5.48 | — |
| HYFT | MindWalk Holdings Corp. | $64.84M | $1.38 | — |
News headlines (Yahoo Finance, 1h cache)
Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
2026-08-13 20:15 · Yahoo
Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s Disease
2026-07-23 10:00 · Yahoo
Serina Therapeutics Appoints Farrell Simon to its Board of Directors
2026-07-22 20:30 · Yahoo
Gannet BioChem and Serina Therapeutics Enter Development Partnership Supporting SER-252 Program
2026-06-30 13:01 · Yahoo
Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit
2026-04-07 10:00 · Yahoo
Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan
2026-04-02 20:13 · Yahoo
Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
2026-07-24 10:00 · Yahoo
Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
2026-07-09 16:10 · Yahoo
Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
2026-05-14 20:20 · Yahoo
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
2026-05-13 12:06 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.